Advocate Leadership Summit

About the Annual Advocate Leadership Summit

For nearly 30 years, NBCC has been a leader in supplying the education, tools and training that empowers breast cancer survivors and other advocates to make their own informed decisions and to take leadership roles in clinical, scientific, policy and legislative decision making that affects breast cancer research, healthcare and public policy.  

NBCC’s Advocate Leadership Summit is an annual gathering of breast cancer advocates from across the country and around the world. Participants attend sessions on the latest scientific research, training in effective advocacy strategies and presentations by respected researchers in the field, grassroots leaders from around the country and prominent public policy experts. The Advocate Leadership Summit is the premier breast cancer advocacy event that attracts women and men from the U.S and other countries. Attendees include breast cancer survivors, caregivers, patient advocates and many others who are affected by breast cancer.

Save the Date for Next Year!

The 2022 Advocate Leadership Summit will be held in-person from April 30 – May 2, 2022 at the Park Hyatt Hotel in Washington, DC. Our annual Lobby Day on Capitol Hill will follow on May 3. Mark your calendars and stay tuned for more information!

*Note: Proof of full COVID-19 vaccination status, as per CDC guidelines, will be required to attend all of NBCC’s in-person events.

About the 2021 Virtual Summit

Due to the coronavirus pandemic, NBCC hosted a 2021 Virtual Advocate Leadership Summit from May 13 – 15, 2021, culminating in a Virtual Lobby Day on May 18, 2021.

The 2021 program included an array of exciting plenary sessions featuring some of the most distinguished voices in breast cancer research and advocacy. Drs. Otis Brawley and Lucile Adams Campbell joined Roslyn Holliday Moore and Ivis Febus-Sampayo in a fascinating and timely discussion of disparities in breast cancer and the ways in which we might overcome them. NBCC President Fran Visco sat down with NBCC co-founder Dr. Susan Love to talk about the organization’s roots. Drs. Cyrus Ghajar, Keith Knutson and Alana Welm gave their annual update on their work with NBCC’s Artemis Project and how this work is fostering innovative breast cancer research, including the development of a preventative vaccine. Attendees also heard from Drs. Matt Hepburn and Robert Cook-Deegan, as well as NBCC advocate Pat Haugen, about Operation Warp Speed and similar initiatives and the ways in which they might inform important developments in breast cancer. There was also an engaging political plenary featuring Neera Tanden of the Center for American Progress and Jennifer Klein of the White House Gender Policy Council in a discussion about the Biden administration and its approach to women’s health.

Attendees were also able to enjoy a variety of virtual workshops aimed at honing their scientific understanding and advocacy skills. They heard from Capitol Hill staffers on crucial issues like how to get their legislator’s attention, how to engage with them at home, and how to navigate advocacy during these sharply divided political times. They heard from Dr. Sara Tolaney about the science behind immune checkpoint inhibitors, Dr. Daniel Douek about breast cancer and the microbiome, and Dr. Nathaniel Wang about mRNA vaccines and how they work.

Despite the Summit being held virtually, it remained NBCC’s mission to ensure that, even as these challenging times continue, the needs of breast cancer patients and survivors will not be forgotten.

View the full 2021 Virtual Advocate Leadership Summit agenda here.